m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00662
|
[1], [2], [3] | |||
: m6A sites
Indirect
Enhancement
RNA modification
HMGA2
HMGA2
METTL1
Methylation
: modification sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 14 (METTL14) | WRITER | |||
| m6A Target | microRNA 375 (MIR375) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> N7-methylguanosine (m7G) | ||||
| Epigenetic Regulator | Methyltransferase-like protein 1 (METTL1) | WRITER | View Details | ||
| Regulated Target | High mobility group protein HMGI-C (HMGA2) | View Details | |||
| Crosstalk Relationship | m6A → m7G | Enhancement | |||
| Crosstalk Mechanism | m6A modification indirectly impacts RNA modification through downstream signaling pathways | ||||
| Crosstalk Summary | METTL14 interacts with microRNA 375 (MIR375), increasing its m6A level and promoting its physical interaction with High mobility group protein HMGI-C (HMGA2), which was regulated by METTL1-mediated m7G modification. | ||||
In-vitro Model |
A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
| Caco-2 | Colon adenocarcinoma | Homo sapiens | CVCL_0025 | ||
| HCT 8 | Colon adenocarcinoma | Homo sapiens | CVCL_2478 | ||
| HCT 116 | Colon carcinoma | Homo sapiens | CVCL_0291 | ||
References
: m6A sites
: modification sites